Position in OCGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$136,506
+$55,563 QoQ
Shares Held
89,220
+99.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#6
of 35 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CORA CAPITAL ADVISORS LLC holds $358,486 across 2 Biotechnology names. OCGN ranks #2 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
356 | $221,980 | |
| 2 | OCGN |
Ocugen, Inc.
This page
|
89,220 | $136,506 |
All Filings in OCGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,506 | 89,220 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $80,943 | 44,720 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $40,693 | 30,143 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $38,538 | 23,643 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $16,143 | 16,643 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $11,749 | 16,643 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $13,397 | 16,643 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $16,519 | 16,653 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $18,837 | 12,153 | Shares | Sole | 2024-08-02 | |
| No filing history on record for this holder in this stock. | ||||||